Mustafa Huseini, MD
Gastroenterology · Owosso, MINPI 1073613808
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,718 of the $5,369 with a category attached, or 69.3%. 21 manufacturers reported payments, led by Olympus Corporation Of The Americas at 59.3% of the total. Reporting peaked in 2023 at $2,358 and has fallen 91.2% since, to $209 in 2025.
Across 92 payments — averaging $58.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$3K
- Apollo Endosurgery US Inc$1K
- AbbVie$217
- Gilead$118
- Intuitive Surgical$108
- Regeneron Healthcare Solutions, Inc.$72
- plus $524 from 15 others
What the payments were for
- Travel & lodging$3,71869%
- Food & beverage$1,62130%
- Education$140%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 32 | $3,181 |
| Apollo Endosurgery US Inc | 10 | $1,149 |
| AbbVie | 11 | $217 |
| Gilead | 7 | $118 |
| Intuitive Surgical | 2 | $108 |
| Regeneron Healthcare Solutions, Inc. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Olympus America Inc. | 2 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $60 |
| ERBE USA Inc | 1 | $50 |
| Endogastric Solutions, Inc | 3 | $46 |
| Boston Scientific | 3 | $46 |
| Madrigal Pharmaceuticals | 2 | $37 |
| Bristol Myers Squibb | 2 | $32 |
| Merck | 1 | $23 |
| QOL Medical, LLC | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Phadia US Inc. | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Sanofi | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,369 in reported general payments places this provider in the 70th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 85 | $1,375 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 34 | $1,004 |
| Pantoprazole Sodium | 35 | $842 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 18 | $339 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Owosso
- Kimberly BrownDetroit$733K
- Dilip MoonkaDetroit$611K
- Philip SchoenfeldAnn Arbor$539K
- Michelle Muza-MoonsAnn Arbor$481K
- Partha NandiTroy$377K
- Bradford WhitmerSaint Clair Shores$206K
- Mohammed BarawiSt Clair Shores$193K
- Stuart GordonDetroit$178K
- Mohamad AlsibaeRoyal Oak$127K
- Allison SchulmanAnn Arbor$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.